Monday, November 5, 2001
Tripping Up in Qatar
More than just cheap drugs
When Boehringer Ingelheim announced in July 2000 that it would provide its Viramune tablets for the prevention of mother-to-child transmission of HIV-1 free of charge to developing countries for five years, the company expected a flood of applications.
"However, this was not the case," said spokesperson Judith von Gordon. "Although the drug fills a critical